Page last updated: 2024-08-24

triptonide and Nasopharyngeal Neoplasms

triptonide has been researched along with Nasopharyngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, MB; Lu, PH; Lv, Y; Song, Y; Wang, SS; Wu, GP; Xu, XC; Zhang, ZQ; Zuo, Y	1

Other Studies

1 other study(ies) available for triptonide and Nasopharyngeal Neoplasms

Article	Year
Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling. Cancer letters, 2019, 02-28, Volume: 443 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Injections, Intraperitoneal; Male; Mice; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; RNA-Binding Proteins; RNA, Long Noncoding; Signal Transduction; Triterpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019

Article

Year

Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.

Cancer letters, 2019, 02-28, Volume: 443

Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Injections, Intraperitoneal; Male; Mice; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; RNA-Binding Proteins; RNA, Long Noncoding; Signal Transduction; Triterpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019